Gary Falcetano, PA, is the U.S. Scientific Affairs Manager for Allergy in ImmunoDiagnostics at Thermo Fisher Scientific. A licensed physician assistant with more than 25 years of diverse experience in emergency and disaster medicine, primary care, and allergy and immunology.
By getting to the root cause of patients’ allergies with detailed symptom histories from patients coupled with history, informed comprehensive allergy testing can help uncover hidden allergies, ensure both effective care and smarter resource utilization, and improve patient safety.
Diagnosing PFAS can be challenging, but establishing a thorough symptom history along with specific IgE blood testing can build a fuller picture of patients’ allergic triggers and sensitizations, helping clinicians develop accurate, tailored treatment recommendations and ultimately improve their patients’ quality of life.
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases
Climate change not only impacts patients with respiratory allergies, but it also has potential broad and emerging impacts on patients with food allergies and overall public health.
Getting the correct food allergy diagnosis leads to increased diet diversity and potentially improved nutrition when suspected allergies are ruled out, making it critical to take the right diagnostic approach from the beginning.